Skip to main content
. 2022 Sep 14;10(9):e005136. doi: 10.1136/jitc-2022-005136

Figure 5.

Figure 5

Kaplan-Meier curves reporting the progression-free survival (A) and overall survival (B) in Low and High RANKL patient stratified according to RANKL median value. RANKL, receptor activator of nuclear factor kappa-Β ligand.